Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial symbols : CDNA save search
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed
Published: 2022-05-26 (Crawled : 14:00) - prnewswire.com
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
trial
UPDATE -- CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community
Published: 2022-03-23 (Crawled : 12:00) - biospace.com/
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: 3.44%
H: 0.0%
C: 0.0%
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
|
| O: -2.81%
H: 4.35%
C: -2.69%
trial
CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community
Published: 2022-03-15 (Crawled : 01:00) - globenewswire.com
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: -18.24%
H: 0.8%
C: -2.98%
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
|
| O: 0.96%
H: 9.73%
C: 9.52%
als trial tiona
CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study
Published: 2021-12-13 (Crawled : 18:00) - biospace.com/
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
als renal trials trial kidney
HAGENS BERMAN, NATIONAL TRIAL ATTOREYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations
Published: 2021-10-30 (Crawled : 16:20) - prnewswire.com
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
| Email alert
Add to watchlist
trial
CareDx Supports Vir Biotechnology’s Clinical Trial Recruitment Efforts for COMET-ICEEffort underscores CareDx’s commitment to the transplant community
Published: 2021-03-23 (Crawled : 12:00) - biospace.com/
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
|
| O: -1.06%
H: 0.98%
C: -4.2%
biotech technology iot trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.